Filing Details

Accession Number:
0001012975-12-000219
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-06-28 18:01:06
Reporting Period:
2012-06-26
Filing Date:
2012-06-28
Accepted Time:
2012-06-28 18:01:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
911326 Synageva Biopharma Corp GEVA Biological Products, (No Disgnostic Substances) (2836) 561808663
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1253170 Srinivas Akkaraju C/O New Leaf Venture Partners
2500 Sand Hill Road, Suite 203
Menlo Park CA 94025
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Disposition 2012-06-26 28,827 $40.16 1,340,283 No 4 S Indirect See footnotes
Common Disposition 2012-06-27 313,451 $39.70 1,026,832 No 4 S Indirect See footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnotes
No 4 S Indirect See footnotes
Footnotes
  1. Represents shares owned directly by New Leaf Ventures II, L.P., a limited partnership of which the sole general partner is New Leaf Venture Associates II, L.P., a limited partnership of which the sole general partner is New Leaf Venture Management II, L.L.C. ("NLVM II"). Dr. Srinivas Akkaraju ("Akkaraju"), in his capacity as member of NLVM II, may be deemed to beneficially own the shares to which this Form 4 relates. Dr. Akkaraju disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.